These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 33455436)
1. Safety of Intravenous Olanzapine Administration at a Tertiary Academic Medical Center. Hunt NF; McLaughlin KC; Kovacevic MP; Lupi KE; Dube KM Ann Pharmacother; 2021 Sep; 55(9):1127-1133. PubMed ID: 33455436 [TBL] [Abstract][Full Text] [Related]
2. Safety of Intravenous Push Levetiracetam Compared to Intravenous Piggyback at a Tertiary Academic Medical Center: A Retrospective Analysis. Alkazemi A; McLaughlin KC; Chan MG; Schontz MJ; Anger KE; Szumita PM Drug Saf; 2022 Jan; 45(1):19-26. PubMed ID: 34716562 [TBL] [Abstract][Full Text] [Related]
3. Safety of Intravenous Push Lacosamide Compared With Intravenous Piggyback at a Tertiary Academic Medical Center. McLaughlin K; Carabetta S; Hunt N; Schuler BR; Ting C; Tran LK; Szumita PM; Anger KE Ann Pharmacother; 2021 Feb; 55(2):181-186. PubMed ID: 32686466 [TBL] [Abstract][Full Text] [Related]
4. A Large Retrospective Cohort of Patients Receiving Intravenous Olanzapine in the Emergency Department. Martel ML; Klein LR; Rivard RL; Cole JB Acad Emerg Med; 2016 Jan; 23(1):29-35. PubMed ID: 26720055 [TBL] [Abstract][Full Text] [Related]
5. Safety of Intravenous Push Valproate Compared with Intravenous Piggyback at a Tertiary Academic Medical Center. Wang FY; McLaughlin KC; Schontz MJ; DeGrado JR; Dannemiller RE Clin Drug Investig; 2024 Mar; 44(3):175-181. PubMed ID: 38363545 [TBL] [Abstract][Full Text] [Related]
6. A Prospective Observational Study of Patients Receiving Intravenous and Intramuscular Olanzapine in the Emergency Department. Cole JB; Moore JC; Dolan BJ; O'Brien-Lambert A; Fryza BJ; Miner JR; Martel ML Ann Emerg Med; 2017 Mar; 69(3):327-336.e2. PubMed ID: 27823873 [TBL] [Abstract][Full Text] [Related]
7. A Retrospective Comparison of the Effectiveness and Safety of Intravenous Olanzapine Versus Intravenous Haloperidol for Agitation in Adult Intensive Care Unit Patients. Wang M; Yankama TT; Abdallah GT; Eche IJ; Knoph KN; Wong A; Patel P; Hsu D; Eche IM J Intensive Care Med; 2022 Feb; 37(2):222-230. PubMed ID: 33426981 [TBL] [Abstract][Full Text] [Related]
8. Safety of Intravenous Push Ertapenem Compared to Intravenous Piggyback at a Tertiary Academic Medical Center. Corrado MJ; Riselli A; McLaughlin KC; Szumita PM; Anger KE J Pharm Pract; 2023 Apr; 36(2):281-285. PubMed ID: 34384303 [No Abstract] [Full Text] [Related]
9. Safety of intravenous push administration of beta-lactams within a healthcare system. Marsh K; Ahmed N; Decano A; Dubrovskaya Y; Jen SP; Siegfried J; Chen XJC; Merchan C Am J Health Syst Pharm; 2020 Apr; 77(9):701-708. PubMed ID: 34278415 [TBL] [Abstract][Full Text] [Related]
11. The Use, Safety, and Efficacy of Olanzapine in a Level I Pediatric Trauma Center Emergency Department Over a 10-Year Period. Cole JB; Klein LR; Strobel AM; Blanchard SR; Nahum R; Martel ML Pediatr Emerg Care; 2020 Feb; 36(2):70-76. PubMed ID: 28697164 [TBL] [Abstract][Full Text] [Related]
12. Atypical Antipsychotic Safety in the CICU. Hanna MP; Adie SK; Ketcham SW; Deshmukh A; Gondi K; Abdul-Aziz AA; Prescott HC; Thomas MP; Konerman MC Am J Cardiol; 2022 Jan; 163():117-123. PubMed ID: 34794647 [TBL] [Abstract][Full Text] [Related]
13. Safety of intravenous push thiamine administration at a tertiary academic medical center. McLaughlin K; Joyal K; Lee S; Corrado M; Marquis K; Anger K; Szumita P J Am Pharm Assoc (2003); 2020; 60(4):598-601. PubMed ID: 31932197 [TBL] [Abstract][Full Text] [Related]
14. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation]. Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I Encephale; 2005; 31(2):235-46. PubMed ID: 15959450 [TBL] [Abstract][Full Text] [Related]
15. Intravenous Olanzapine for the Management of Agitation: Review of the Literature. Khorassani F; Saad M Ann Pharmacother; 2019 Aug; 53(8):853-859. PubMed ID: 30758221 [No Abstract] [Full Text] [Related]
16. Intramuscular olanzapine vs. intramuscular short-acting antipsychotics: safety, tolerability and the switch to oral antipsychotic medication in patients with schizophrenia or acute mania. Chandrasena R; Dvoráková D; Lee SI; Loza N; Mosolov SN; Osváth P; Pregelj P; Walton RJ; Karagianis J; Treuer T Int J Clin Pract; 2009 Aug; 63(8):1249-58. PubMed ID: 19558486 [TBL] [Abstract][Full Text] [Related]
17. Single- and multiple-dose pharmacokinetic, safety, and tolerability profiles of olanzapine long-acting injection: an open-label, multicenter, nonrandomized study in patients with schizophrenia. Mitchell M; Kothare P; Bergstrom R; Zhao F; Jen KY; Walker D; Johnson J; McDonnell D Clin Ther; 2013 Dec; 35(12):1890-908. PubMed ID: 24184052 [TBL] [Abstract][Full Text] [Related]
18. A naturalistic study of intramuscular haloperidol versus intramuscular olanzapine for the management of acute agitation. MacDonald K; Wilson M; Minassian A; Vilke GM; Becker O; Tallian K; Cobb P; Perez R; Galangue B; Feifel D J Clin Psychopharmacol; 2012 Jun; 32(3):317-22. PubMed ID: 22544013 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of Time to Administration, Benzodiazepine Use, and Safety of Intravenous Push Levetiracetam in a Neuro-Spine Intensive Care Unit. Adams T; Greathouse K Neurocrit Care; 2021 Dec; 35(3):789-793. PubMed ID: 34081297 [TBL] [Abstract][Full Text] [Related]
20. Potential complications of combining intramuscular olanzapine with benzodiazepines in emergency department patients. Wilson MP; MacDonald K; Vilke GM; Feifel D J Emerg Med; 2012 Nov; 43(5):889-96. PubMed ID: 20542400 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]